LabCentral Announces $22.4 Million in Committed Funding for LabCentral 238 including New Sponsors Thermo Fisher Scientific and Waters Corporation

Scale-up bio-manufacturing facility is expected to open in November 2021

01-Mar-2021 - LabCentral, the first-of-its-kind shared laboratory space designed as a launchpad for high-potential biotech startups, announced a total of $22.4 million in sponsorship commitments for LabCentral 238, a fully functional life sciences laboratory with a focus on scale-up bio-manufacturing. Thermo ...

Evolva in collaboration with Roquette

04-Jan-2012 - Evolva Holding SA announced the signing of an agreement with Roquette Frères SA for joint research and development of novel and optimised biosynthetic production routes for an ingredient with important applications in food products.The collaboration will run for up to 4.5 years and involve c. 7% ...

Almac continues biocatalysis business growth with a further $4m R&D investment

11-Oct-2010 - The need for green, economic, robust and scaleable processes for the synthesis of chiral APIs and intermediates prompted Almacto build and fully integrate a biocatalysis group into its service portfolio. Last year Almac launched carbonyl reductase, transaminase, hydrolase, nitrilase, and nitrile ...

PolyTherics moves lead candidate into development and manufacturing with DSM BioSolutions

09-Sep-2010 - DSM BioSolutions, DSM’s microbial fermentation CMO business unit and PolyTherics Limited announced that they have entered into an agreement for the process development and manufacture of PolyTherics’ lead biobetter product, HiPEG™ IFN alpha-2a. PolyTherics has applied its HiPEG™ site-specific ...

Pevion Biotech and CEVEC Pharmaceuticals Sign Exclusive License Option Agreement

28-May-2010 - Pharmaceuticals announced the signing of an exclusive license option agreement with Pevion Biotech. The agreement enables Pevion Biotech to exclusively use CEVEC’s transient CAP-T™ cell expression technology to manufacture and commercialize a protein antigen for vaccination against a widespread ...

High value order for Linde-KCA for an innovative Biotechnology Project in Leuna

18-Jan-2010 - As the result of the Europe wide tender related to the project Chemical Biotechnology Process Centre in Leuna, Saxony-Anhalt the engineering and contracting company Linde-KCA-Dresden GmbH, a subsidiary in The Linde Group, has been awarded the contract to act as general contractor for planning, ...

Oxford Expression Technologies and Eden Biodesign Sign Co-marketing Agreement

04-Feb-2009 - Oxford Expression Technologies (OET) and Eden Biodesign have announced that they have signed a co-marketing agreement. Under the terms of the agreement, OET will offer its customers access to Eden Biodesign’s process development, clinical trial cGMP manufacturing and analytical development ...

Pharming and Aslan Group sign License Agreement for Lactoferrin

Pharming to receive significant milestone and royalty payments

20-Nov-2008 - Pharming Group NV and Aslan Group A.S. from Istanbul, Turkey announced that they have signed a full licensing agreement to further develop, manufacture and market Pharming's human lactoferrin product (hLF). Earlier in 2008, the companies concluded a commercialization and supply agreement for the ...

Eden Biodesign signs marketing services agreement with human genome sciences

New alliance will increase Human Genome Sciences' global marketing reach for large scale cGMP manufacturing services and provides a seamless range of services for clients from process development to 20,000L scale production

15-Aug-2008 - Eden Biodesign Ltd. announced that they have entered into a marketing services agreement with Human Genome Sciences, Inc. Under the terms of the agreement, Eden Biodesign will use its expertise and global presence in the biopharmaceutical contract manufacturing market to assist HGS in identifying ...

DIREVO Announces Incorporation of Industrial Biotechnology Subsidiary

29-Jul-2008 - DIREVO Biotech AG announced the incorporation of a fully owned subsidiary named DIREVO Industrial Biotechnology GmbH. The new company was formed to spin-out DIREVO's industrial biotechnology business unit established at the beginning of 2007 and the recently acquired AC Biotec GmbH. The new ...